Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients

被引：0
|
作者：
Daphne SC Lee
Sook-Yee Yoon
Lai Meng Looi
Peter Kang
In Nee Kang
Kavitta Sivanandan
Hany Ariffin
Meow Keong Thong
Kin Fah Chin
Nur Aishah Mohd Taib
Cheng-Har Yip
Soo-Hwang Teo
机构：
[1] Sime Darby Medical Centre,Cancer Research Initiatives Foundation
[2] University Malaya Medical Centre,Department of Pathology
[3] University Malaya,Department of Paediatrics
[4] University Malaya Cancer Research Institute,Department of Surgery
[5] University Malaya Medical Centre,undefined
[6] University Malaya,undefined
[7] University Malaya Medical Centre,undefined
[8] University Malaya,undefined
[9] University Malaya Medical Centre,undefined
[10] University Malaya,undefined
来源：
Breast Cancer Research | / 14卷
关键词：
Breast Cancer; TP53 Mutation; Contralateral Breast Cancer; Germline TP53 Mutation; TP53 Mutation Carrier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations
    Dite, GS
    Jenkins, MA
    Southey, MC
    Hocking, JS
    Giles, GG
    McCredie, MRE
    Venter, DJ
    Hopper, JL
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) : 448 - 457
  • [32] TP53 mutations in BRCA1 and BRCA2-related breast cancer: distinctive spectrum and structural distribution.
    Chappuis, PO
    Greenblatt, MS
    Bond, JP
    Hamel, N
    Foulkes, WD
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 59 - 59
  • [33] Screening for mutations in TP53, MSH2 and BRCA1 by constant denaturant gel electrophoresis (CDGE).
    Lothe, RA
    Kyrkjevo, HT
    Nesland, JM
    BorresenDale, AL
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (05): : ST14 - ST14
  • [34] Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms
    Schulz, Eduard
    Valentin, Angelika
    Ulz, Peter
    Beham-Schmid, Christine
    Lind, Karin
    Rupp, Verena
    Lackner, Herwig
    Woelfler, Albert
    Zebisch, Armin
    Olipitz, Werner
    Geigl, Jochen
    Berghold, Andrea
    Speicher, Michael R.
    Sill, Heinz
    JOURNAL OF MEDICAL GENETICS, 2012, 49 (07) : 422 - 428
  • [35] Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes
    Apostolou, Paraskevi
    Dellatola, Vasiliki
    Papathanasiou, Athanasios
    Kalfakakou, Despoina
    Fountzilas, Elena
    Tryfonopoulos, Dimitrios
    Karageorgopoulou, Sofia
    Yannoukakos, Drakoulis
    Konstantopoulou, Irene
    Fostira, Florentia
    CANCERS, 2024, 16 (13)
  • [36] Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: Characterizing a Northeast Brazilian Population
    Felix G.E.S.
    Abe-Sandes C.
    Machado-Lopes T.M.B.
    Bomfim T.F.
    Guindalini R.S.C.
    Santos V.C.S.A.R.
    Meyer L.
    Oliveira P.C.
    Neiva J.C.
    Meyer R.
    Romeo M.
    Toralles M.B.
    Nascimento I.
    Abe-Sandes K.
    Human Genome Variation, 1 (1)
  • [37] Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer
    Petridis, Christos
    Arora, Iteeka
    Shah, Vandna
    Moss, Charlotte L.
    Mera, Anca
    Clifford, Angela
    Gillett, Cheryl
    Pinder, Sarah E.
    Tomlinson, Ian
    Roylance, Rebecca
    Simpson, Michael A.
    Sawyer, Elinor J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (07) : 1162 - 1168
  • [38] Analytical and technical validation of a cost-effective diagnostic test for BRCA1, BRCA2 and TP53
    Sen, Manimala
    Agrawal, Pooja
    Vittal, Vikram P.
    Ghosh, Mithua
    Sheela, M. L.
    Vishwanath, Divya
    Kumari, Kiran
    Swetha, N. S. N.
    Pathak, Vaibhavi
    Deshpande, Gouri
    Mannan, Ashraf
    Gadkari, Rupali
    Kapoor, Suman
    Yadhav, Jamuna
    Yousuff, Mohammed
    Sankaran, Satish
    Hariharan, Ramesh
    Ramamoorthy, Preveen
    Subramanian, Kalyanasundaram
    Gupta, Vaijayanti
    CANCER RESEARCH, 2015, 75
  • [39] Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany
    Ute Hamann
    Xuan Liu
    Nikola Bungardt
    Hans Ulrich Ulmer
    Gunther Bastert
    Hans-Peter Sinn
    European Journal of Human Genetics, 2003, 11 : 464 - 467
  • [40] Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus
    Loizidou, M.
    Marcou, Y.
    Anastasiadou, V.
    Newbold, R.
    Hadjisavvas, A.
    Kyriacou, K.
    CLINICAL GENETICS, 2007, 71 (02) : 165 - 170
12345